|
HS Code |
897358 |
| Generic Name | Propranolol Hydrochloride |
| Brand Names | Inderal, Inderal LA, InnoPran XL |
| Drug Class | Beta-blocker |
| Dosage Forms | Tablets, extended-release capsules, oral solution, injectable solution |
| Route Of Administration | Oral, intravenous |
| Indications | Hypertension, angina pectoris, arrhythmias, migraine prophylaxis, essential tremor |
| Mechanism Of Action | Non-selective beta-adrenergic receptor blocker |
| Pregnancy Category | C (US FDA) |
| Common Side Effects | Bradycardia, hypotension, fatigue, dizziness, gastrointestinal disturbances |
| Contraindications | Bronchial asthma, sinus bradycardia, greater than first-degree heart block, cardiogenic shock, overt cardiac failure |
As an accredited Propranolol Hydrochloride factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The packaging for Propranolol Hydrochloride features a 100g sealed amber glass bottle with a tamper-evident cap and clear labeling. |
| Shipping | Propranolol Hydrochloride should be shipped in tightly sealed, clearly labeled containers, protected from light and moisture. It must comply with all chemical transport regulations, including appropriate hazard labeling. Depending on quantity and region, it may require documentation such as a Safety Data Sheet (SDS) and should be handled by trained personnel. |
| Storage | Propranolol Hydrochloride should be stored at controlled room temperature, ideally between 20°C and 25°C (68°F to 77°F). Keep the container tightly closed, protected from light and moisture. Store away from incompatible substances and out of reach of children and pets. Avoid excessive heat, and do not freeze. Follow local regulations for the storage of pharmaceuticals. |
|
Purity 99%: Propranolol Hydrochloride with a purity of 99% is used in pharmaceutical formulations for hypertension treatment, where high purity ensures maximum therapeutic efficacy and patient safety. Molecular weight 295.8 g/mol: Propranolol Hydrochloride of molecular weight 295.8 g/mol is used in clinical research for cardiovascular disorders, where precise molecular weight facilitates accurate dosage calculations. Melting point 162°C: Propranolol Hydrochloride with a melting point of 162°C is used in tablet manufacturing, where its controlled melting behavior enables optimal processing and stability. Particle size <20 microns: Propranolol Hydrochloride with a particle size less than 20 microns is used in oral solid dosage forms, where fine particle size improves dissolution rate and bioavailability. Stability temperature up to 40°C: Propranolol Hydrochloride with stability temperature up to 40°C is used in long-term storage applications, where enhanced thermal stability maintains drug potency during distribution. Water solubility 50 mg/mL: Propranolol Hydrochloride with water solubility of 50 mg/mL is used in injectable solutions, where high solubility allows for concentrated formulations and efficient administration. Optical rotation -25° to -29°: Propranolol Hydrochloride with optical rotation between -25° to -29° is used in chiral drug synthesis, where specific optical properties confirm correct enantiomeric form and therapeutic consistency. |
Competitive Propranolol Hydrochloride prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Propranolol Hydrochloride has quietly remained a staple among prescription medicines for good reason. Developed as a non-selective beta-adrenergic antagonist, it steps in not just for one condition but covers a broad range—from controlling high blood pressure and easing angina to calming the nerves of patients facing stage fright or migraine attacks. While competitors like atenolol focus purely on the heart, propranolol stands out by crossing into the brain, impacting both heart rate and anxiety symptoms alike. This unique profile comes from its ability to cross the blood-brain barrier, something that has influenced prescribing habits all over the world. Every time I’ve known someone prescribed propranolol, it wasn’t just for the heart—they needed help with everything from tremor to social anxiety. That ability to do double duty gives it a place in many medicine cabinets.
Walk into a pharmacy and most shelves carry propranolol in several strengths. Common tablet forms, like 10mg, 40mg, and extended-release capsules, offer options for both the patient just starting out and the long-time user working with a steady maintenance dose. The convenience of tailored doses has real meaning—especially for the elderly and those struggling to juggle multiple medications. Patients often share that swallowing a small tablet before an exam or speech feels less intimidating than many alternatives, especially compared to some newer, more complex therapy regimens that involve injections or repeated clinic visits. The extended-release forms boost this sense of ease, smoothing out the peaks and valleys patients can feel with shorter-acting medication. This steady level can make the difference in daily life, reducing interruptions for additional dosing and letting people focus on what matters most.
Years ago, my neighbor found comfort in propranolol after relentless migraines refused to let up. Friends in the performing arts world then recommended it again for performance anxiety—another use where this beta blocker shines. The way propranolol seems to ‘smooth the edges’ of a stressful event or health flare-up shows up in so many conversations, from students facing big presentations to older adults worried about irregular heartbeats. Whether fighting hypertension, seeking relief from a pounding heart, or calming nerves, propranolol offers an accessible, time-tested choice. Its non-selective action means it doesn't just isolate one receptor type—helpful for some, not always for others. Unlike the newer, highly selective beta blockers, propranolol acts on both beta-1 and beta-2 receptors. This wider scope means it helps in conditions like essential tremor and even thyroid storm, conditions where a narrow approach wouldn’t make the same impact.
While medicine cabinets contain several beta blockers, propranolol’s roots go back the furthest. Many modern beta blockers, like metoprolol or bisoprolol, cater mainly to cardiovascular conditions. They settle into predictable routines, often causing fewer side effects in patients with respiratory concerns. By contrast, propranolol takes a broader approach. For someone managing migraine or essential tremor, the alternatives rarely offer comparable relief. Propranolol is fat-soluble, which explains its ability to cross into the brain. That’s both the source of its power and where the competition shifts. For someone with chronic anxiety or a neurologic disorder, drugs like atenolol or nadolol simply don't bring the same flexibility. Yet propranolol users also need to watch for extra caution if they’ve got asthma, since its non-selective mechanism can impact breathing more than the cardio-selective cousins. Doctors and pharmacists—myself watching friends and family—choose propranolol for its ability to hit more than one target. It may not be the right pick for every heart, but the advantage is clear when the symptoms go beyond blood pressure alone.
Few things matter as much in medicine as experience. Propranolol came to market more than fifty years ago, a span of time that lets researchers and patients both weigh its strengths and weaknesses. Clinical trials have tracked its effects with various illnesses, and a wealth of real-world stories reinforce its reliability. You can spot patients across the world who rely on it to carry them through public speaking, exams, or migraine-prone months. That said, safety is more than a number. Doctors review heart rate, blood pressure, and see how a patient handles the medication before raising the dose. Sometimes adjustments are needed, or someone has to switch to something newer or more selective. Finding that sweet spot often comes from careful listening and shared decision-making. Because propranolol influences many organ systems at once, it demands attention to underlying breathing problems and blood sugar levels, especially in older adults or those with diabetes. It’s become standard practice to avoid this drug in people with asthma or severe COPD, since blocking beta-2 receptors may tighten airways. Facts learned through years of research and patient stories fuel this advice—the sort of experience that can’t be replaced by chemistry alone.
Folks share different tales about their time on propranolol. Some mention cold fingers, others describe vivid dreams, especially if the dose runs high. Doses that are a bit too strong can leave you tired in the afternoon, with a pulse that seems to lag behind normal daily rushes and worries. People with diabetes sometimes note that propranolol can mask low blood sugar, turning a classic warning sign—like a racing heart—into a less obvious one. That makes patient education, especially for those on insulin, a key piece of the puzzle. No medication brings only benefits. Propranolol’s impact on the body sneaks up in subtle ways for some, with fatigue or shortness of breath sometimes appearing in people who didn’t expect it. But many share that feeling better—mentally sharper, more in control during stressful times, less battered by daily chest pounding—far outweighs the occasional side effect. These stories underline why regular follow-up matters, and why clinicians often start doses low and make changes based on more than just textbook rules.
In my experience, doctors rarely just prescribe propranolol and walk away. They keep an eye on blood pressure, heart rate, and the unique ways symptoms like tremor or anxiety shift over time. Blood work may come into play for long-term users, and patient feedback is often valued as highly as chart data. For those at home, having a blood pressure monitor can give peace of mind, while a notepad for recording symptoms or side effects helps track the journey. Family members sensitive to seasonal coughs or asthma learn to look out for signs of trouble. Pharmacies nowadays provide in-depth counseling for new prescriptions—sometimes offering tips to help with timing the doses around meals or other medications.
Choosing propranolol over newer medications is often about real-world results as much as research. Years on the market have allowed for many adjustments and comparisons to crop up in the literature. Head-to-head trials with metoprolol or bisoprolol have shown mixed results—sometimes the newer options edge ahead for pure heart protection, sometimes the older, well-studied drug provides better relief for symptoms outside the heart. That trust, built up over decades, carries weight for patients and families who have watched loved ones find relief after months or years of trial and error. It’s also the drug of choice for some rare conditions, such as certain types of aggressive thyroid disease or as an adjunct in treating a pheochromocytoma. Propranolol builds its reputation on this flexibility and depth of use.
The world of medicine has shifted in the past ten years, with new medications flooding the market and guidelines updating every few years. As new selective beta blockers came out, some experts feared propranolol would fade into the background. Instead, it has sometimes found niches where others couldn’t quite match its profile. One challenge commonly brought up involves asthma—and not just in the hospital. Community providers know that propranolol and similar non-selective beta blockers can cause problems for those with breathing issues. That risk is balanced against its benefits with support from careful screening and regular lung function monitoring. For pregnant patients dealing with severe hypertension or tachycardia, other therapies often jump ahead in the queue, backed by updated safety data. But for performance anxiety, essential tremor, or migraine, propranolol doesn’t budge easily from the top of the list.
Many neurologists and primary care physicians reach for propranolol in cases of essential tremor, even after trials with other medicines fall flat. It seems to blunt the edge of involuntary shaking for countless patients, often with only a mild dose needed. The connection to migraine prevention has a long clinical track record, with major studies confirming lower attack rates and less severe symptoms for regular users. While patients still need to stay alert to potential side effects, especially if other medical conditions are in play, the risk-benefit tally for neurological issues sits weighted in favor of propranolol. It’s the decades of patient feedback—stories from the exam room and support group—that shape this advice as much as the latest review article.
Performance anxiety, social anxiety, and panic attacks all bring their own stormy weather. By dampening response in the body’s adrenaline system, propranolol gives many people the breathing space to take on life’s challenges without feeling hijacked by fear. For every story in a textbook, there’s someone in the arts, in business, or in exam rooms who put trust in a single dose before a big event. Unlike benzodiazepines that can bring drowsiness or drug dependency, propranolol usually leaves people with a clearer head, avoiding the glazed feeling so many want to sidestep. It isn’t a cure for deep anxiety—therapy and lifestyle changes still matter—but for those single moments where nerves rise above all else, propranolol often brings just enough calm to step into the spotlight.
One of the strongest arguments for propranolol is its accessibility. As a generic medication, cost rarely stands in the way of prescription. People in countries without robust insurance systems often point to the affordability of propranolol as a reason to stick with it over newer or brand-name formulations. This access can make the difference in underserved regions or for families managing multiple health issues on a limited budget. Beyond price, availability matters. Pharmacies almost always have propranolol in stock, removing obstacles for those who need treatment for migraine, anxiety, or cardiovascular problems on short notice. This stands out in the patient testimonies I’ve heard—people relieved to walk out of the pharmacy with their prescription on day one.
For the working parent, college student, or retiree balancing time and appointments, propranolol’s dosing regimen often fits more smoothly into daily routines than some alternatives. Single daily doses with extended-release forms and familiar, easily split tablets support individualized treatment without complicated schedules. This convenience means better adherence, and better adherence supports real health gains. Talking to patients and clinicians alike, the ease of taking propranolol—no fuss, no complicated pill organizers—remains a major reason for its longevity in medical practice.
Doctors and health authorities keep an eye on the evolving landscape. New beta blockers and non-beta blocker therapies for heart and neurological problems continue to hit the market. Selective drugs promise fewer side effects, and combination therapies attract interest for those needing tighter control over blood pressure or complex arrhythmias. Despite all these advances, propranolol’s legacy isn’t simply pushed aside. Instead, it encourages direct comparison in clinical trials, sharpens patient monitoring, and sparks conversation about choice, risk, and outcome. Researchers explore whether new formulations or dose regimens might keep side effects low without sacrificing benefits.
Almost every pharmacy or clinic has stories of patients who tried several medications before finding relief with propranolol. That track record, born out of thousands of patient encounters, matters when guidelines leave room for clinical judgment. Providers consider family history, concurrent medical conditions, cost, and the patient’s lived experience before making a recommendation. Even in a world of personalized medicine, the real-world success of a drug counts for plenty. This blend of clinical evidence, patient experience, and ongoing review keeps propranolol at the center of many treatment pathways, while reminding everyone involved that health is personal and rarely follows a simple script.
No discussion of propranolol would be complete without admitting its drawbacks. Some patients face low blood pressure, slow heart rates, or mood swings. Others, especially those with asthma or diabetes, need more frequent monitoring or should look elsewhere. This is why working with knowledgeable clinicians—and honestly sharing changes in symptoms—carries such importance. Patients also need to know that propranolol doesn’t pair well with certain medications, including some antidepressants and medicines used for severe mental illness. Drug interactions, changing kidney or liver function, and shifts in physical health can all affect how well the medication works or how safe it remains.
Routine follow-up, clear instructions from healthcare providers, and patient education form the backbone of safe long-term use. The most success comes when patients and providers revisit dose, timing, and overall benefit on a regular basis. Open conversations, aided by accurate home monitoring and honest symptom tracking, allow for real decisions about staying on propranolol or exploring alternatives. An informed patient stands a better chance of sidestepping side effects, recognizing problems early, and building treatment into their real lives—not just the exam room.
Age, overall health, coexisting conditions, and goals of care all influence propranolol’s place in therapy. Yet it remains a reminder of the strength found in drugs that have stood the test of time, taught healthcare professionals and patients alike what works, and continue to adapt to changing needs and expectations. Healthcare is more personalized than ever, and no medication fits everyone. Still, propranolol’s unique place as a bridge between heart health, neurology, and psychiatry shows there’s still value in experience-backed, accessible therapies like this one. Those weighing their options—be it for migraines, high blood pressure, or the jitters of a big presentation—can make decisions grounded in evidence, cost, convenience, and the wisdom of those who went before.
Improvements will likely come not just from new drugs, but from better education, careful monitoring, and honest conversations at every step. Patients benefit most when decisions draw on both science and the lived reality of day-to-day life. Teaching about risks, monitoring for drug interactions, and making dose adjustments when new issues emerge build trust and keep health outcomes moving in the right direction. For some, new therapies may leap ahead as science uncovers their advantages. For others—those seeking tried-and-true relief backed by decades of real-world use—propranolol remains an essential part of the conversation. The future of care likely belongs to those who blend innovation with proven wisdom, never forgetting the patient at the center.